HomeMarketsEarningsEvolus CEO on Medical Aesthetics Growth & New Products

Evolus CEO on Medical Aesthetics Growth & New Products

Evolus is a performance beauty company focused exclusively on cash-pay aesthetics. Its flagship product, Jeuveau®, is the fastest-growing neurotoxin in the U.S., capturing 13% market share in just five years. Evolus is now expanding its portfolio with Evolysse™, a line of unique injectable hyaluronic acid dermal fillers expected to launch in Q2 2025, marking the first major innovation in the filler market in over a decade.

Morning Trade Live

30 Jan 2025

SHARE

ON AIR
2:00 pm
Market On Close
12:00 am
Gamma On
REPLAY
12:30 am
Gamma On
REPLAY
1:00 am
Gamma On
REPLAY
1:30 am
Gamma On
REPLAY
2:30 am
Gamma On
REPLAY
3:00 am
Gamma On
REPLAY
3:30 am
Gamma On
REPLAY
4:00 am
Gamma On
REPLAY
5:00 am
Gamma On
REPLAY
6:00 am
Gamma On
REPLAY
7:00 am
Morning Movers
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
ON AIR
2:00 pm
Market On Close
3:30 pm
Market Overtime
REPLAY
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
7:00 pm
Market Overtime
REPLAY
7:30 pm
Market Overtime
REPLAY
8:00 pm
Gamma On
REPLAY
9:00 pm
Market Overtime
REPLAY
9:30 pm
Market Overtime
REPLAY
education
10:00 pm
Inside the Mind of a Trader
REPLAY
education
10:30 pm
Inside the Mind of a Trader
REPLAY
education
11:00 pm
Inside the Mind of a Trader
REPLAY
education
11:30 pm
Your First Trade
REPLAY

Schwab Network's Newsletters

Daily insights for every investor